Jacobs Levy Equity Management
NXTC icon

Jacobs Levy Equity Management’s NextCure NXTC Stock Holding History

Jacobs Levy Equity Management’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-15,483
Closed -$1.11M – 1054
2021
Q4 		$1.11M Sell
15,483
-606
-4% -$50.7K 0.01% 723
2021
Q3 		$1.3M Buy
16,089
+11,127
+224% +$976K 0.01% 698
2021
Q2 		$478K Sell
4,962
-1,455
-23% -$149K ﹤0.01% 868
2021
Q1 		$771K Buy
6,417
+1,165
+22% +$169K 0.01% 790
2020
Q4 		$687K Buy
+5,252
New +$679K 0.01% 808

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Jacobs Levy Equity Management's NXTC Position: Q1 2022 in Review

Jacobs Levy Equity Management sold out of NextCure (NXTC) in Q1 2022, closing a stake of 15,483 shares — an estimated $1.11M sold.

Jacobs Levy Equity Management first reported a position in NXTC in Q4 2020 and held it in 5 quarters. The position peaked at $1.3M in Q3 2021. 59 funds tracked by Wall St. Rank hold NXTC as of Q1 2022.

  • Jacobs Levy Equity Management reported no remaining NextCure position as of Q1 2022 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 15,483 NextCure shares in Q1 2022, an estimated $1.11M.
  • Jacobs Levy Equity Management first reported a position in NextCure in Q4 2020 and held it in 5 quarters.
  • Jacobs Levy Equity Management's NextCure position peaked at $1.3M in Q3 2021.
  • 59 funds tracked by Wall St. Rank held NextCure as of Q1 2022.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2022, filed 16 May 2022.